Terms: = Leukemia AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Staging
4 results:
1. An analysis of prognostic factors and the five-year survival rate in childhood acute lymphoblastic leukemia.
Karimi M; Yarmohammadi H; Sabri MR
Med Sci Monit; 2002 Dec; 8(12):CR792-6. PubMed ID: 12503037
[TBL] [Abstract] [Full Text] [Related]
2. Red cell enzymopathies in leukemias.
Devi GS; Prasad MH; Pushpavathi K; Reddy PP; Rao DN
Indian J Exp Biol; 1996 Dec; 34(12):1224-8. PubMed ID: 9246916
[TBL] [Abstract] [Full Text] [Related]
3. [Lymphoblastic non-Hodgkin's lymphoma: estimation of the survival of patients with the disseminated form of the disease (stages III and IV) treated by the LSA2-L2 protocol].
Pisón Garcés J; Buñuel Alvarez JC; Domínguez Fenollé MP; Castillo Laita JA; Cenarro Guerrero T; Monreal Gálvez MJ; Arana Navarro T; Hernández Gayá A
An Esp Pediatr; 1991 Dec; 35(6):381-4. PubMed ID: 1793185
[TBL] [Abstract] [Full Text] [Related]
4. Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
Vecchi V; Serra L; Pession A; Rosito P; Paolucci P; Burnelli R; Vivarelli F; Mancini AF; Paolucci G
Pediatr Hematol Oncol; 1986; 3(3):217-28. PubMed ID: 3153234
[TBL] [Abstract] [Full Text] [Related]
